Replies to post #417087 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Gus McCrae,

This is how Linda operates to keep everyone guessing. She also knows that by bringing a bunch of “surprises” to the market all at once the disadvantage of being on OTC markets is minimized by the level of interest generated leading to up listing and other news. Best wishes.

[biosectinvestor]

Yes, such consulting arrangements are NOT material. It can and likely would be argued by any competent counsel.

Hiring counsel or any advisors to explore future options or ways of managing one’s listing or any number of legal planning arrangements or listings or expansions, or any kind of person who might help a company think about future issues… none of that is necessarily material. They are not c-suite executives, they are there to talk about possible options and possible futures. So no, it’s not material and there is no “faulty” or bad disclosure. And besides you know about it anyway.